about
Clustered base substitutions in CTP synthetase conferring drug resistance in Chinese hamster ovary cellsImpaired 2',3'-dideoxy-3'-thiacytidine accumulation in T-lymphoblastoid cells as a mechanism of acquired resistance independent of multidrug resistant protein 4 with a possible role for ATP-binding cassette C11Prediction of Cancer Drug Resistance and Implications for Personalized MedicineTranscripts from amplified sequences of an inherited homogeneously staining region in chromosome 1 of the house mouse (Mus musculus)Influence of pharmacogenetics on response and toxicity in breast cancer patients treated with doxorubicin and cyclophosphamide.Molecular epidemiologic approaches to urinary tract infection gene discovery in uropathogenic Escherichia coli.Continuous in situ electrochemical monitoring of doxorubicin efflux from sensitive and drug-resistant cancer cells.Essential features of the P-glycoprotein pharmacophore as defined by a series of reserpine analogs that modulate multidrug resistance.Identification of members of the P-glycoprotein multigene family.Gene expression analysis of tumor spheroids reveals a role for suppressed DNA mismatch repair in multicellular resistance to alkylating agents.Expression of multi-cytokine resistance and multi-growth factor independence in advanced stage metastatic cancer. Malignant melanoma as a paradigmDo glutathione and related enzymes play a role in drug resistance in small cell lung cancer cell lines?Changes in subcellular doxorubicin distribution and cellular accumulation alone can largely account for doxorubicin resistance in SW-1573 lung cancer and MCF-7 breast cancer multidrug resistant tumour cells.Investigation of the relationship between altered intracellular pH and multidrug resistance in mammalian cells.Cyclosporin A and verapamil have different effects on energy metabolism in multidrug-resistant tumour cells.Immunohistochemical detection of multidrug resistance associated P-glycoprotein in tumour and stromal cells of human cancers.Multidrug resistance-associated antigens on drug-sensitive and -resistant human tumour cell lines.SDZ 280-446, a novel semi-synthetic cyclopeptolide: in vitro and in vivo circumvention of the P-glycoprotein-mediated tumour cell multidrug resistance.Hypoxia-induced drug resistance: comparison to P-glycoprotein-associated drug resistanceLevels of expression of the mdr1 gene and glutathione S-transferase genes 2 and 3 and response to chemotherapy in multiple myeloma.Reversal of adriamycin resistance by lonidamine in a human breast cancer cell lineReversal of multidrug resistance by surfactants.Daunorubicin pharmacokinetics and the correlation with P-glycoprotein and response in patients with acute leukaemia.Identification of genetic changes associated with drug resistance by reverse in situ hybridizationCancer cell progression and chemoimmunotherapy--dual effects in the induction of resistance to therapyDaunorubicin and doxorubicin but not BCNU have deleterious effects on organotypic multicellular spheroids of gliomas.Acquired multicellular-mediated resistance to alkylating agents in cancerAssociation of ABCB1 and SLC22A16 Gene Polymorphisms with Incidence of Doxorubicin-Induced Febrile Neutropenia: A Survey of Iranian Breast Cancer PatientsOn the interaction of doxorubicin with oleate ions: fluorescence spectroscopy and liquid-liquid extraction study.In vitro evaluation of the potential of aclarubicin in the treatment of small cell carcinoma of the lung (SCCL).Multidrug resistance (mdr) genes in human cancer.Comparison of (99m)Tc-sestamibi and doxorubicin to monitor inhibition of P-glycoprotein function.Protein expression profiles indicative for drug resistance of non-small cell lung cancerCystic fibrosis. 4. Abnormalities of airway epithelial function and the implications of the discovery of the cystic fibrosis gene.Design opportunities for actively targeted nanoparticle vaccines.Biodistribution and pharmacokinetic analysis of Paclitaxel and ceramide administered in multifunctional polymer-blend nanoparticles in drug resistant breast cancer modelModeling kinetics of subcellular disposition of chemicals.Tissue distribution, gender-divergent expression, ontogeny, and chemical induction of multidrug resistance transporter genes (Mdr1a, Mdr1b, Mdr2) in miceInterleukin 6: a fibroblast-derived growth inhibitor of human melanoma cells from early but not advanced stages of tumor progression.Molecular analysis of the multidrug transporter, P-glycoprotein.
P2860
Q24309193-7249D89A-9FC2-4B71-A11F-83C76129B0E2Q24534863-F1A8B05B-5029-460F-A865-9814F9A0DF14Q26770581-912C2C3B-E2F3-4B99-B7A0-2D452962CD3CQ33522705-B6B2D30C-77C5-4F42-B89D-A51B02364EABQ33747406-385E585F-F81B-4F45-BB26-1D1D8DE8400FQ34003883-304BC6DC-4C3F-413F-B109-8D3EEBAFABEFQ34169297-C8F4D04A-72D9-4026-8BA1-7552388B3EBEQ34287731-E531EA61-AD37-4AF0-9364-226603498324Q35558945-FB222E32-124F-43B2-A9EB-789C1EC72B52Q35663759-F1B266D5-385D-4BF9-B3E1-CDD318FB6C57Q35804856-C4197B09-51F3-4119-9432-27DDB507E994Q35977182-4A9737BB-70BE-489B-BE7B-F20BA61D89C9Q35977902-30FA1F9D-A3F5-4F12-9F70-51D5E511FA12Q35981655-0CE82940-A4B0-46D3-849A-9FBB1BDC1D3AQ35982832-B633239F-12F1-467A-B59B-D675504B0A97Q35983196-3F5C7CCD-FE67-4424-BC97-F8417206B821Q35992775-467B64A4-D503-4B89-94A9-ED845D6D6C5EQ35992919-A7A652E7-3F4A-4D31-A34C-33076342D014Q35993291-C3DC6612-5A5E-4B37-A943-C58CEB0E7A74Q35993668-87D4956B-0817-4CC4-B9B1-EC7A1D6FA02DQ35993734-A351CAB8-0F9A-4DC8-A1ED-7332F39A09DAQ35994358-E252D515-0A3F-42E9-9114-2F04A5C6616CQ36080042-A2B8998D-5329-4EA4-BDAC-66DFA764FD4BQ36116003-E109A30C-E006-4EF4-B795-9C68DE5B4F80Q36135064-BCA5980D-0D08-492E-A800-5B1A998395C2Q36135496-54C96E5A-A3F9-4ECB-A5BB-7F9734A9843FQ36236006-141D89F9-2D74-4111-B70F-87A014101022Q36236476-7E406AB7-6D32-4B43-86A9-A4576BA6D5DAQ36460848-5EF9A4F5-9C6A-47C0-AC13-4997348C4082Q36467852-186367BB-5BE2-4959-9F90-D203F7696CB4Q36495579-08CE3521-AFA0-473B-AA3F-64C41B0C8AC8Q36622566-EE34B2F0-E9FD-456F-9160-3A94E3ED9BEAQ36623993-868673BF-F0D2-4A7E-BBFA-9C7706D0C1F1Q36639844-1E65BEBC-2318-4CE8-870A-D43E185D0677Q37062606-E0394C9A-321C-4A11-842D-40D30803B9BEQ37107015-99E8480F-CB67-4D30-B4F7-7FD36F06F13FQ37194304-6696CB27-B788-4D71-B69F-9CC02AD2AA44Q37196030-FB75F3A8-FD9E-43A6-A94E-D0D8967102A7Q37228532-25874357-6E8B-40FC-82A3-75C946C8A256Q37323494-C7C0C008-2810-49D3-9DDD-83811D81575C
P2860
description
1988 nî lūn-bûn
@nan
1988年の論文
@ja
1988年論文
@yue
1988年論文
@zh-hant
1988年論文
@zh-hk
1988年論文
@zh-mo
1988年論文
@zh-tw
1988年论文
@wuu
1988年论文
@zh
1988年论文
@zh-cn
name
Mechanism of multidrug resistance.
@en
Mechanism of multidrug resistance.
@nl
type
label
Mechanism of multidrug resistance.
@en
Mechanism of multidrug resistance.
@nl
prefLabel
Mechanism of multidrug resistance.
@en
Mechanism of multidrug resistance.
@nl
P2093
P1476
Mechanism of multidrug resistance.
@en
P2093
P304
P356
10.1016/0304-419X(88)90006-6
P577
1988-08-01T00:00:00Z